Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

162 results about "Mammary fluid" patented technology

Lactation-promoting and menstruation-inducing Chinese medicinal composition for puerperae

The invention provides a lactation-promoting and menstruation-inducing Chinese medicinal composition for puerperae, which can regulate the functions of promoting lactation, inducing menstruation, removing blood stasis, replenishing blood, nourishing qi and promoting body fluid of the puerperae comprehensively. According to the lactation-promoting and menstruation-inducing Chinese medicinal composition, anemone clematis stem, corn stigma, lettuce seed, dwarf lilyturf tuber and rose are used as a monarch medicine and have the effects of promoting blood circulation, regulating menstruation and promoting lactation; cassia bark, chestnut, medlar, cinnamomvine and loofah are used as a minister medicine and exert a secondary effect to solve the problem of galactostasis and realize the functions of dredging collaterals and inducing menstruation; carrot, pumpkin, glutinous rice, papaya and malt are used as an assistant medicine, have a coordinative effect in a formula or have a treatment effect of enhancing the monarch medicine and the minister medicine and inhibit the toxic and side effects of other medicines; and almond, Chinese date, prepared rehmannia root, turmeric and cowherb seed assists the medicines to exert the effects of promoting blood circulation, promoting lactation and blending the medicines. According to the formula, blood circulation-promoting and blood stasis-reducing medicines are supplemented on the basis of lactation promotion and menstruation induction, and the blood stasis-reducing medicines are combined with medicines for treating various accompanied symptoms, so that an effect of blending the medicines is achieved, and a reasonable formula of the Chinese medicinal composition for treating postpartum galactostasis, mammary swelling, acute mastitis, blood stasis pain, body deficiency and hypodynamia is formed.
Owner:河北永丰药业有限公司

Infant feed and method

InactiveUS20170172167A1Raise countReduces bacterial cell countMilk preparationFood scienceBreast feedNutrition
The present disclosure relates generally to a composition for feeding an infant. More particularly, the disclosure relates to a nutritional composition for feeding an infant comprising a stem-cell deficient first component and a second component comprising breast milk stem cells (BSCs). The second component is added to the first component, and the BSCs partially or fully replenish the stem-cell deficient first component with respect to BSCs. In some embodiments the first component is stem-cell deficient human breast milk and the second component comprises BSCs from the infant's mother's own milk. The compositions of the present disclosure have been developed primarily as a personalized, nutritional composition providing the beneficial effects of an infant's mother's own BSCs to the infant while not being able to receive the full benefits of being breastfed directly.
The present disclosure also relates to a composition for feeding an infant and to processes of their production. In particular, the disclosure relates to a composition for feeding an infant comprising a first and a second component, wherein the first component provides the majority of the nutritional value to said composition, and wherein the second component comprises at least one live bacterium from human breast milk or the lactating human mammary gland. The disclosure has been developed primarily as a composition for feeding a mother's own infant, wherein the composition comprises processed human breast milk with a substantially reduced live bacterial cell count as compared to unprocessed breast milk but which at least one live bacterium, from the mother's own breast milk, is added such as to partially or fully replenish the processed human breast milk with respect to the at least one live bacterium. More particular, the composition is a personalised composition for feeding the mother's own preterm infant.
The present invention also related to the combination of BSC and bacterial replenishment as described herein.
Owner:MEDELA HLDG AG

Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom

The invention relates to a method of producing a protein of interest, comprising making a non-human transgenic mammal that produces said protein in its milk, obtaining said milk from the non-human transgenic mammal and purifying said protein of interest from the milk. Transgenic bovine animals were generated, which are able to produce human growth hormone in mammary glands. The method involves cloning of a genetic construct encoding hGH gene and beta casein promoter conveniently in an expression vector. It also includes transfection procedures into fetal bovine somatic cells, generally fibroblasts, and the nuclear transfer into enucleated bovine oocytes, generating thus transgenic embryos. The method also includes other procedures to generate transgenic embryos for the further expansion of the transgenic herd, such as the subcloning of transgenic female bovines, the superovulation of transgenic cows and their insemination with semen from a non-transgenic or a transgenic male bovine, and the superovulation of non-transgenic cows and their insemination with semen from a transgenic male bovine. Afterwards, transgenic embryos give rise to transgenic cattle that produce human growth hormone in huge amounts in their milk, from which the hormone is completely purified and analysed to fulfill all the requirements for the manufacture of a pure biopharmaceutical product.
Owner:STERRENBELD BIOTECH NORTH AMERICA

Medicinal composition for treating hypogalactia symptom of dairy cow and preparation method thereof

The invention discloses a medicinal composition for treating hypogalactia symptom of a dairy cow and a preparation method thereof. The medicinal composition comprises the following raw materials of lythrum, radix aucklandiae, girald jasmine root, the root of three-nerved spicebush, rhizoma nardostachyos, Omei meadowrue herb, aspongopus, urtica dioica, pericarpium citri reticulatae viride, jujube, radix bupleuri, paederia scandens, nutgrass galingale rhizome, kohlrabi, lucid ganoderma, Chinese buckeye seed, calyx of singharanut, aiomatic turmeric root-tuber, woody hawksbeard root, rose, Japanese cayratia herb, semen raphani, rhizome of large-headed atractylodes, Australian cowplant root or leaf, hawthorn, hindu datura seed fruit, malt, rice-grain sprout, japanese balanophora, dangshen, turnip, Chinese yam and ficus pumila fruit. The medicinal composition disclosed by the invention has the benefits that the medicinal composition is mainly used for nourishing spleen and regulating qi and is assisted for reinforcing qi and enriching blood; the immunity of the dairy cow is improved, the lactation yield, the milk-fat percentage, the milk protein content, the lactose content and the content of dry substances in the milk can be improved; the breast plump and normal development of a nipple are promoted; milk is full, and the phenomenon of sudden decrease of appetite or inability to eat is avoided; the medicinal composition has the advantages of few toxic or side effects and remarkable effect; in addition, normal growth of mammary gland and other organs of the dairy cow can be better guaranteed.
Owner:SHANDONG NEW HOPE LIUHE GROUP

Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom

The invention relates to a method of producing a protein of interest, comprising making a non-human transgenic mammal that produces said protein in its milk, obtaining said milk from the non-human transgenic mammal and purifying said protein of interest from the milk. Transgenic bovine animals were generated, which are able to produce human growth hormone in mammary glands. The method involves cloning of a genetic construct encoding hGH gene and beta casein promoter conveniently in an expression vector. It also includes transfection procedures into fetal bovine somatic cells, generally fibroblasts, and the nuclear transfer into enucleated bovine oocytes, generating thus transgenic embryos. The method also includes other procedures to generate transgenic embryos for the further expansion of the transgenic herd, such as the subcloning of transgenic female bovines, the superovulation of transgenic cows and their insemination with semen from a non-transgenic or a transgenic male bovine, and the superovulation of non-transgenic cows and their insemination with semen from a transgenic male bovine. Afterwards, transgenic embryos give rise to transgenic cattle that produce human growth hormone in huge amounts in their milk, from which the hormone is completely purified and analysed to fulfill all the requirements for the manufacture of a pure biopharmaceutical product.
Owner:STERRENBELD BIOTECH NORTH AMERICA

Breast pump

The invention relates to the technical field of breast pumping articles, and particularly relates to a breast pump. The breast pump comprises a breast milk collector, a pumping source and a breast milk pumping shield, wherein the pumping source is provided with a relief port and an air suction port; the breast milk pumping shield is provided with a relief passageway and a breast milk outlet; the breast milk outlet is communicated with the breast milk collector through a first hose; the breast milk collector is communicated with the air suction port of the pumping source through a second hose; the relief passageway is communicated with the relief port of the pumping source through a third hose; when the breast pump is used, the breast milk pumping shield covers the breasts and does not need to be held by hands as the breast milk pumping shield is separated from the breast milk collector; the pumping source is started for pumping, and air pressure in the breast milk collector and the breast pumping shield turns to be negative pressure; and when the air pressure is lower than the pressure in the breasts, breast milk is pumped out from the nippers into the breast milk pumping shield, and then the pumping source relieves, the pressure in the breast milk pumping shield is increased instantly after relief, the pressure of the breast milk collector is still in the negative pressure state, and the breast milk rapidly flows to the breast milk collector from the breast milk pumping shield through the first hose under the function of the pressure difference, so as to achieve the effect that no residual breast milk is left.
Owner:东莞市宝雅母婴用品有限公司

Methods for producing sialyloligosaccharides in a dairy source

The present invention provides methods for producing sialyloligosaccharides in situ in dairy sources and cheese processing waste streams, prior to, during, or after processing of the dairy source during the cheese manufacturing process. The methods of the present invention use the catalytic activity of alpha(2-3) trans-sialidases to exploit the high concentrations of lactose and alpha(2-3) sialosides which naturally occur in dairy sources and cheese processing waste streams to drive the enzymatic synthesis of alpha(2-3) sialyllactose. alpha(2-3) sialyloligosaccharides produced according to these methods are additionally encompassed by the present invention. The invention also provides for recovery of the sialyloligosaccharides produced by these methods. The invention further provides a method for producing alpha(2-3) sialyllactose. The invention additionally provides a method of enriching for alpha(2-3) sialyllactose in milk using transgenic mammals that express an alpha(2-3) trans-sialidase transgene. The invention also provides for recovery of the sialyllactose contained in the milk produced by this transgenic mammal either before or after processing of the milk. Transgenic mammals containing an alpha(2-3) trans-sialidase encoding sequence operably linked to a regulatory sequence of a gene expressed in mammary tissue are also provided by the invention.
Owner:NEOSE TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products